Inactive Instrument

Antibiotice SA Share Price Bucharest S.E.

Equities

Pharmaceuticals

End-of-day quote Bucharest S.E.
- RON - Intraday chart for Antibiotice SA

Financials

Sales 2022 497M 107M 8.44B Sales 2023 615M 132M 10.44B Capitalization 937M 201M 15.89B
Net income 2022 38M 8.16M 645M Net income 2023 81M 17.4M 1.37B EV / Sales 2022 0.92 x
Net Debt 2022 79.25M 17.02M 1.34B Net Debt 2023 64.49M 13.85M 1.09B EV / Sales 2023 1.63 x
P/E ratio 2022
9.87 x
P/E ratio 2023
11.5 x
Employees -
Yield 2022
1.4%
Yield 2023
3.3%
Free-Float 17.57%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 64 31/12/86
Director of Finance/CFO 56 31/12/90
Chief Tech/Sci/R&D Officer 58 04/01/03
Members of the board TitleAgeSince
Chief Executive Officer 64 31/12/86
Director/Board Member 41 25/08/21
Director/Board Member 48 25/08/21
More insiders
Antibiotice SA is a Romania-based company primarily active in the pharmaceutical industry. The Company manufactures drugs in five pharmaceutical forms: powder for injectable solutions and suspensions, capsules, tablets, suppositories and preparations. The Company's products are designed to treat a range of diseases, including infectious, dermatology, cardiovascular, digestive and musculoskeletal system related. The Company operates eight certified production lines. Its portfolio includes products for human and veterinary use, pharmaceutical ingredients and biological fertilizers. Additionally, the Company is engaged in the research and development activities.
More about the company